RealLine SARS-Influenza A+B
BIORON GmbHThe RealLine SARS-Influenza A+B Kit is intended for the differential detection of the SARS-CoV-2 RNA with targetgenes E and N and the Influenza A and B Virus RNA RUO – Research Use Only
The RealLine SARS-Influenza A+B Kit is intended for the differential detection of the SARS-CoV-2 RNA with targetgenes E and N and the Influenza A and B Virus RNA RUO – Research Use Only
Advances in microscopy reveal source of phonons’ puzzling behavior
Researchers from Glasgow University believe they can solve the mystery of the origin of the water on earth
The INNOVANCE Anti-Xa assay for anticoagulant therapy management delivers fully automated, ready-to-use testing for heparins, rivaroxaban, apixaban, and edoxaban
Smart Microscopy from ZEISS simplifies biomedical routine lab work
The discovery offers fundamental new insights into the management of energy
Meet the scientists at Aqua Pennsylvania who are streamlining EPA method 537 to increase water sample throughput
Labs seek guidance in reducing their environmental footprint by increasing efficiency but overall convey optimism on sustainability efforts
The assays have shown efficacy against the newest variants of concern
Hear from leading experts and explore tools to advance your work using 3D cell culture
Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR
The agreement will allow materials science researchers to benefit from solutions combining HORIBA’s advances in AFM instrumentation with Qnami’s innovation in quantum sensing
Leading clinical scientists and health professionals have come together to discuss the latest diagnostic and point-of-care solutions at this critical time
Pre-coated plates and an easy-to-use self-coating liquid allow flexible experimental designs with maximum convenience
COVID-DPR is a virtual collection of high-resolution microscopic COVID-related human tissue images hosted at the National Institutes of Health
Money will help fund the international DUNE experiment
Uncover the remarkable evolution of point-of-care diagnostics as we examine the significant breakthroughs achieved over the years and explore exciting future directions
Report identifies need for improved assays across numerous disease areas and more education around LC-MS/MS technologies